Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome. [electronic resource]
Producer: 20120815Description: 2039-49 p. digitalISSN:- 1945-7197
- Adult
- Antihypertensive Agents -- therapeutic use
- Blood Glucose -- drug effects
- Blood Pressure -- drug effects
- Body Composition -- drug effects
- Body Weight -- drug effects
- Cushing Syndrome -- complications
- Diabetes Mellitus, Type 2 -- complications
- Female
- Glucose Intolerance -- complications
- Hormone Antagonists -- administration & dosage
- Humans
- Hydrocortisone -- blood
- Hypertension -- complications
- Male
- Middle Aged
- Mifepristone -- administration & dosage
- Quality of Life
- Quinolines -- blood
- Receptors, Glucocorticoid -- antagonists & inhibitors
- Urea -- analogs & derivatives
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.